Rejoinder to "The Prevalence of Cognitive Impairment Is Not Increasing in the United States: A Critique of Hale et al. (2020)".

Hale, Jo Mhairi; Schneider, Daniel C; Gampe, Jutta; Mehta, Neil K; Myrskylä, Mikko

Hale, Jo Mhairi; Schneider, Daniel C; Gampe, Jutta; Mehta, Neil K; Myrskylä, Mikko.

Afiliação

Hale JM; From the University of St Andrews, Scotland, United Kingdom.
Schneider DC; Max Planck Institute for Demographic Research, Rostock, Germany.
Gampe J; Max Planck Institute for Demographic Research, Rostock, Germany.
Mehta NK; Max Planck Institute for Demographic Research, Rostock, Germany.
Myrskylä M; The University of Texas Medical Branch, Galveston, TX.

Epidemiology ; 32(5): 717-720, 2021 09 01.

Article em En | MEDLINE | ID: mdl-34224473

Assuntos

Disfunção Cognitiva; Disfunção Cognitiva/epidemiologia; Humanos; Prevalência; Estados Unidos/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google